Delivery Order SPE2DB24D2003-SPE2DB26FXCT6
- Not listed
- The Defense Logistics Agency awarded a $3,633.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on July 18, 2025, with completion scheduled for July 21, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The product will be delivered to AmerisourceBergen's...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on April 22, 2025, with completion scheduled for April 23, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under a child delivery order structure, leveraging the company's broader contracting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $2,313.04, with completion scheduled for October 27, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate headquarters location in...
- The Defense Logistics Agency awarded a $11,046.77 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 3, 2025, with completion scheduled for September 4, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on August 7, 2025, with completion targeted for August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens valued at $1,904.63 with a completion date of June 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $2,720.90 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on September 3, 2025, with an ultimate completion date of September 4, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens in 0.5 mL quantities, with a ceiling value of $3,011.78. This is a firm fixed-price delivery order with no set-aside designation, scheduled for completion by October 24, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $3,265.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. The award was made without set-aside designation through open competition, with an ultimate completion date of October 21, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $2,955.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for supply of Mounjaro 7.5 mg/0.5 mL pens on July 15, 2025, with completion targeted for July 16, 2025. This non-set-aside delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB26FXCT6Delivery Order
The Defense Logistics Agency awarded a $7,754.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a non-set-aside competitive award with an ultimate completion date of October 27, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical procurement. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive portfolio of federal awards demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, including specialty medications for military and veteran healthcare systems. The firm fixed-price structure and routine issuance of delivery orders under this IDC reflect the company's established role as a primary source for federal pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 10/24/25 |